Sidney Rosenblatt

1.6k total citations · 1 hit paper
13 papers, 1.3k citations indexed

About

Sidney Rosenblatt is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Sidney Rosenblatt has authored 13 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Cardiology and Cardiovascular Medicine and 2 papers in Surgery. Recurrent topics in Sidney Rosenblatt's work include Diabetes Treatment and Management (3 papers), Prostate Cancer Diagnosis and Treatment (2 papers) and Pharmacology and Obesity Treatment (2 papers). Sidney Rosenblatt is often cited by papers focused on Diabetes Treatment and Management (3 papers), Prostate Cancer Diagnosis and Treatment (2 papers) and Pharmacology and Obesity Treatment (2 papers). Sidney Rosenblatt collaborates with scholars based in United States, Canada and United Kingdom. Sidney Rosenblatt's co-authors include Susan S. Braithwaite, S Aronoff, Annette Mathisen, J. Egan, Kenneth E. Robertson, N. Bradly Glazer, Melvin Prince, Enrico P. Veltri, Harold Bays and Paul B. Moore and has published in prestigious journals such as Diabetes Care, Cancer and The Journal of Urology.

In The Last Decade

Sidney Rosenblatt

13 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.

2000 522 citations S Aronoff, Sidney Rosenblatt et al. Diabetes Care profile →

Peers

Sidney Rosenblatt

EDM

MB

SURGE

PRM

UROLO

Alan G. Meehan United States

Amanda Darekar United Kingdom

Walter Krauwinkel Netherlands

Jan Jaap van Lier United States

Carin Larsson Sweden

David L. Ebel United States

R. F. Bing United Kingdom

Yasuhiro Shigeta Japan

Bimal Malhotra United States

David P. Sonne Denmark

Alan G. Meehan United States

Sidney Rosenblatt

675 ×1.0

EDM

216 ×0.5

MB

311 ×0.8

SURGE

402 ×2.0

PRM

751 ×3.9

UROLO

Citations per year, relative to Sidney Rosenblatt Sidney Rosenblatt (= 1×) peers Alan G. Meehan

Countries citing papers authored by Sidney Rosenblatt

Since Specialization

Citations

This map shows the geographic impact of Sidney Rosenblatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sidney Rosenblatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sidney Rosenblatt more than expected).

Fields of papers citing papers by Sidney Rosenblatt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sidney Rosenblatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sidney Rosenblatt. The network helps show where Sidney Rosenblatt may publish in the future.

Co-authorship network of co-authors of Sidney Rosenblatt

This figure shows the co-authorship network connecting the top 25 collaborators of Sidney Rosenblatt. A scholar is included among the top collaborators of Sidney Rosenblatt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sidney Rosenblatt. Sidney Rosenblatt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Rosenblatt, Sidney, et al.. (2001). The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus. Coronary Artery Disease. 12(5). 413–423. 184 indexed citations

2.

Bays, Harold, Paul B. Moore, Margaret Drehobl, et al.. (2001). Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies. Clinical Therapeutics. 23(8). 1209–1230. 253 indexed citations

3.

Roehrborn, Claus G., John D. McConnell, JAIME BONILLA, et al.. (2000). SERUM PROSTATE SPECIFIC ANTIGEN IS A STRONG PREDICTOR OF FUTURE PROSTATE GROWTH IN MEN WITH BENIGN PROSTATIC HYPERPLASIA. The Journal of Urology. 163(1). 13–20. 195 indexed citations

4.

Aronoff, S, et al.. (2000). Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.. Diabetes Care. 23(11). 1605–1611. 522 indexed citations breakdown →

5.

Hudson, Perry B., Rex Boake, John Trachtenberg, et al.. (1999). Efficacy of finasteride is maintained in patients with benign prostatic hyperplasia treated for 5 years. Urology. 53(4). 690–695. 43 indexed citations

6.

Harris, Steven T., et al.. (1997). Evaluation of indapamide 1.25 mg once daily in elderly patients with mild to moderate hypertension. Journal of Human Hypertension. 11(4). 239–244. 11 indexed citations

7.

Hanson, Cindy L., Charles Lucas, Sidney Rosenblatt, et al.. (1993). Double-blind, placebo-controlled study of ramipril in diabetics with mild to moderate hypertension.. PubMed. 15(1). 79–87. 5 indexed citations

8.

Rosenblatt, Sidney, et al.. (1992). Searching for a Pattern: Repeat Suicide Attempts. Journal of Psychosocial Nursing and Mental Health Services. 30(3). 23–26. 6 indexed citations

9.

Weir, Matthew R., et al.. (1992). A dose escalation trial comparing the combination of diltiazem SR and hydrochlorothiazide with the monotherapies in patients with essential hypertension.. PubMed. 6(2). 133–8. 20 indexed citations

10.

Pool, Peter E., Jerry Herron, Sidney Rosenblatt, et al.. (1989). Sustained‐Release Diltiazem: Duration of Antihypertensive Effect. The Journal of Clinical Pharmacology. 29(6). 533–537. 14 indexed citations

11.

Pool, Peter E., Jerry Herron, Sidney Rosenblatt, et al.. (1988). Metabolic effects of antihypertensive therapy with a calcium antagonist. The American Journal of Cardiology. 62(11). 109–113. 17 indexed citations

12.

Мелмед, Шломо, Shunichi Yamashita, Kálmán Kovács, et al.. (1987). Cushing's syndrome due to ectopic proopiomelanocortin gene expression by islet cell carcinoma of the pancreas. Cancer. 59(4). 772–778. 13 indexed citations

13.

Morley, John E., et al.. (1981). Thyrotropin-Releasing Hormone Increases Plasma Norepinephrine in Man. Hormone Research. 14(1). 18–23. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact